• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

病例报告:剖析一例伴有腋窝复杂情况的男性隐匿性乳腺癌独特病例并全面深入研究文献

Case report: Unraveling a unique case of male occult breast cancer with axillary intricacies and a comprehensive literature dive.

作者信息

Xie Xintong, Kong Xiangyi, Jiang Hongnan, Gao Jidong

机构信息

Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China.

Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

出版信息

Front Oncol. 2025 Feb 11;15:1374032. doi: 10.3389/fonc.2025.1374032. eCollection 2025.

DOI:10.3389/fonc.2025.1374032
PMID:40008002
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11851083/
Abstract

Male breast cancer is a rare neoplasm, accounting for approximately 1% of all breast cancer cases. It typically presents as a painless, retroareolar mass. An exceedingly rare variant is male occult breast cancer, which is primarily characterized by axillary lymph node enlargement without an identifiable primary breast tumor. We report an intriguing case of a septuagenarian patient diagnosed with male occult breast cancer. The patient presented with both axillary lymph node enlargement and an associated axillary skin ulcer, and was subsequently diagnosed with male occult breast cancer with metastases to the axillary and clavicular lymph nodes, as well as more distant sites. His treatment involved a multidisciplinary approach, including HER2-targeted therapy, chemotherapy, axillary lymph node dissection, and radiotherapy. Regular follow-ups have shown that his condition remains stable. Notably, this is the first documented case of male occult breast cancer with distant metastasis that was successfully treated with surgery and radiotherapy following systemic therapy. This case highlights the complex clinical presentation and management of male occult breast cancer. Our findings suggest that surgical intervention may be a feasible option post-downstaging by systemic therapy, even in the presence of distant metastases.

摘要

男性乳腺癌是一种罕见的肿瘤,约占所有乳腺癌病例的1%。它通常表现为无痛性乳晕后肿块。一种极其罕见的变异类型是男性隐匿性乳腺癌,其主要特征是腋窝淋巴结肿大而无明确的原发性乳腺肿瘤。我们报告了一例有趣的病例,一名老年男性患者被诊断为男性隐匿性乳腺癌。该患者表现为腋窝淋巴结肿大及相关的腋窝皮肤溃疡,随后被诊断为男性隐匿性乳腺癌,已转移至腋窝和锁骨淋巴结以及更远处的部位。他的治疗采用了多学科方法,包括HER2靶向治疗、化疗、腋窝淋巴结清扫和放疗。定期随访显示他的病情保持稳定。值得注意的是,这是第一例有文献记载的男性隐匿性乳腺癌伴远处转移的病例,在全身治疗后通过手术和放疗成功治愈。该病例突出了男性隐匿性乳腺癌复杂的临床表现和治疗方法。我们的研究结果表明,即使存在远处转移,手术干预在全身治疗降期后可能是一种可行的选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afcf/11851083/609dac14b718/fonc-15-1374032-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afcf/11851083/bb39e4b5e0dc/fonc-15-1374032-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afcf/11851083/ddb4e25d7ac5/fonc-15-1374032-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afcf/11851083/609dac14b718/fonc-15-1374032-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afcf/11851083/bb39e4b5e0dc/fonc-15-1374032-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afcf/11851083/ddb4e25d7ac5/fonc-15-1374032-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afcf/11851083/609dac14b718/fonc-15-1374032-g003.jpg

相似文献

1
Case report: Unraveling a unique case of male occult breast cancer with axillary intricacies and a comprehensive literature dive.病例报告:剖析一例伴有腋窝复杂情况的男性隐匿性乳腺癌独特病例并全面深入研究文献
Front Oncol. 2025 Feb 11;15:1374032. doi: 10.3389/fonc.2025.1374032. eCollection 2025.
2
Adenocarcinoma of the Breast Presenting as Occult Breast Cancer With Axillary and Supraclavicular Lymph Node Metastasis: A Case Report.以隐匿性乳腺癌伴腋窝及锁骨上淋巴结转移表现的乳腺腺癌:1例报告
Cureus. 2023 May 27;15(5):e39583. doi: 10.7759/cureus.39583. eCollection 2023 May.
3
Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.乳腺癌细胞学确诊腋窝淋巴结转移化疗后病理完全缓解后隐匿性腋窝淋巴结转移的预后意义
Cancer. 2009 Apr 15;115(8):1605-12. doi: 10.1002/cncr.24173.
4
Shifting from axillary dissection to targeted axillary surgery after neoadjuvant treatment: the evolving management of occult breast cancer in a monoinstitutional series of 114 patients.新辅助治疗后从腋窝清扫术转向靶向腋窝手术:114例单中心隐匿性乳腺癌患者的治疗进展
Breast Cancer Res Treat. 2025 Apr;210(3):661-672. doi: 10.1007/s10549-024-07604-3. Epub 2025 Jan 8.
5
Metachronous secondary primary occult breast cancer initially presenting with metastases to the contralateral axillary lymph nodes: report of a case.同时性双侧隐匿性乳腺癌初始表现为对侧腋窝淋巴结转移:病例报告。
Breast Cancer. 2010;17(1):71-4. doi: 10.1007/s12282-009-0097-9. Epub 2009 Mar 4.
6
Occult Invasive Lobular Carcinoma Presenting as an Axillary Skin Metastatic Lesion Underwent Neoadjuvant Endocrine Therapy and Surgical Resection: A Case Report and Review of Literature.以腋窝皮肤转移灶形式出现的隐匿性浸润性小叶癌接受新辅助内分泌治疗及手术切除:1例病例报告并文献复习
Breast Cancer (Dove Med Press). 2022 May 31;14:145-152. doi: 10.2147/BCTT.S366785. eCollection 2022.
7
Malignant adenomyoepithelioma of the breast with axillary lymph node metastasis: a case report and review of the literature.乳腺恶性腺肌上皮瘤伴腋窝淋巴结转移:1例报告并文献复习
Front Oncol. 2025 Mar 6;15:1496057. doi: 10.3389/fonc.2025.1496057. eCollection 2025.
8
Biological significance of occult micrometastases in histologically negative axillary lymph nodes in breast cancer patients using the recent American Joint Committee on Cancer breast cancer staging system.采用最新美国癌症联合委员会乳腺癌分期系统评估乳腺癌患者组织学检查阴性腋窝淋巴结中隐匿性微转移的生物学意义。
Breast J. 2006 Jul-Aug;12(4):294-301. doi: 10.1111/j.1075-122X.2006.00267.x.
9
Unusual Metastatic Lymph Node to Retro-Scapular Area in Occult Breast Cancer: A Case Report.隐匿性乳腺癌罕见的肩胛后区域转移性淋巴结:一例报告
Case Rep Oncol. 2024 Dec 26;18(1):239-245. doi: 10.1159/000543346. eCollection 2025 Jan-Dec.
10
Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy.新辅助化疗治疗患者术前记录的乳腺癌腋窝淋巴结转移灶根除的发生率及影响
Ann Surg. 1999 Jul;230(1):72-8. doi: 10.1097/00000658-199907000-00011.

本文引用的文献

1
Early Local Therapy for the Primary Site in De Novo Stage IV Breast Cancer: Results of a Randomized Clinical Trial (EA2108).新发IV期乳腺癌原发部位的早期局部治疗:一项随机临床试验(EA2108)的结果
J Clin Oncol. 2022 Mar 20;40(9):978-987. doi: 10.1200/JCO.21.02006. Epub 2022 Jan 7.
2
Primary Surgery with Systemic Therapy in Patients with de Novo Stage IV Breast Cancer: 10-year Follow-up; Protocol MF07-01 Randomized Clinical Trial.原发肿瘤切除术联合全身治疗新辅助治疗 IV 期乳腺癌患者:10 年随访;MF07-01 号方案随机临床试验。
J Am Coll Surg. 2021 Dec;233(6):742-751.e5. doi: 10.1016/j.jamcollsurg.2021.08.686. Epub 2021 Sep 13.
3
Novel uses of immunohistochemistry in breast pathology: interpretation and pitfalls.
免疫组织化学在乳腺病理学中的新用途:解读与陷阱。
Mod Pathol. 2021 Jan;34(Suppl 1):62-77. doi: 10.1038/s41379-020-00697-3. Epub 2020 Oct 27.
4
Impact of Breast Surgery in Primary Metastasized Breast Cancer: Outcomes of the Prospective Randomized Phase III ABCSG-28 POSYTIVE Trial.原发转移性乳腺癌乳房切除术的影响:前瞻性随机 III 期 ABCSG-28 POSYTIVE 试验的结果。
Ann Surg. 2019 Jun;269(6):1163-1169. doi: 10.1097/SLA.0000000000002771.
5
Primary tumor resection in stage IV breast cancer: A systematic review and meta-analysis.IV 期乳腺癌的原发肿瘤切除术:系统评价和荟萃分析。
Eur J Surg Oncol. 2018 Oct;44(10):1504-1512. doi: 10.1016/j.ejso.2018.08.002. Epub 2018 Aug 11.
6
Breast Cancer in Men.男性乳腺癌
N Engl J Med. 2018 Jun 14;378(24):2311-2320. doi: 10.1056/NEJMra1707939.
7
Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial.局部区域治疗与转移性乳腺癌中肿瘤原发灶不治疗的比较:一项开放标签随机对照试验。
Lancet Oncol. 2015 Oct;16(13):1380-8. doi: 10.1016/S1470-2045(15)00135-7. Epub 2015 Sep 9.
8
Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer.帕妥珠单抗、曲妥珠单抗和多西他赛用于HER2阳性转移性乳腺癌的治疗
N Engl J Med. 2015 Feb 19;372(8):724-34. doi: 10.1056/NEJMoa1413513.
9
Population-based analysis of occult primary breast cancer with axillary lymph node metastasis.基于人群的伴腋窝淋巴结转移隐匿性乳腺癌分析。
Cancer. 2010 Sep 1;116(17):4000-6. doi: 10.1002/cncr.25197.
10
Randomized phase II trial of first-line trastuzumab plus docetaxel and capecitabine compared with trastuzumab plus docetaxel in HER2-positive metastatic breast cancer.随机 II 期试验:一线曲妥珠单抗联合多西他赛和卡培他滨对比曲妥珠单抗联合多西他赛治疗 HER2 阳性转移性乳腺癌。
J Clin Oncol. 2010 Feb 20;28(6):976-83. doi: 10.1200/JCO.2008.21.6531. Epub 2009 Dec 28.